Delhi-based Dr Dangs selected as central lab for Covaxin human clinical trials

A Delhi-based private laboratory has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India’s indigenous Covid-19 vaccine candidate.

The vaccine is being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

Dr. Dangs Lab said on Wednesday that it has partnered with Bharat Biotech for conducting the trials.